TE
CGEM icon

Tema ETFs’s Cullinan Oncology CGEM Stock Holding History

Tema ETFs’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
62,826
+405
+0.6% +$6.01K 0.04% 272
2026
Q1 		$887K Buy
62,421
+25,457
+69% +$327K 0.06% 258
2025
Q4 		$383K Buy
+36,964
New +$333K 0.03% 413
2025
Q3 		– Sell
-42,692
Closed -$321K – 517
2025
Q2 		$321K Buy
42,692
+3,528
+9% +$28.3K 0.09% 150
2025
Q1 		$296K Buy
39,164
+10,731
+38% +$103K 0.09% 130
2024
Q4 		$346K Buy
+28,433
New +$409K 0.14% 122

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Tema ETFs's CGEM Position: Q2 2026 in Review

Tema ETFs increased its Cullinan Oncology (CGEM) stake by 0.65% in Q2 2026, buying an estimated $6.01K and bringing the position to 62,826 shares worth $1.14M. The position accounts for 0.04% of the portfolio, ranked #272.

Tema ETFs first reported a position in CGEM in Q4 2024 and has held it in 6 quarters since. 184 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Tema ETFs held 62,826 shares of Cullinan Oncology worth $1.14M as of Q2 2026.
  • Tema ETFs bought 405 Cullinan Oncology shares in Q2 2026, an estimated $6.01K.
  • Cullinan Oncology made up 0.04% of Tema ETFs's portfolio in Q2 2026, its #272 holding.
  • Tema ETFs first reported a position in Cullinan Oncology in Q4 2024 and has held it in 6 quarters since.
  • 184 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.